: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.
Impact of Pre‐Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents
Lanzarone, Giuseppe;Cilloni, Daniela;
2025-01-01
Abstract
: Expectation of survival of patients receiving HMA + VEN is influenced by pre-treatment comorbidity burden.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Marconi.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
693.46 kB
Formato
Adobe PDF
|
693.46 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



